This is the limited version of the UCB company profile: Join LinkedIn or Sign In to see more information.
With a unique combination of expertise in biology and chemistry, UCB is a global biopharma focusing on severe diseases in two therapeutic areas - CNS and Immunology. UCB also has a selective presence in primary care. To further boost its innovation, UCB recently established its new Discovery to Proof of Concept organisation, UCB NewMedicines.
New Hires and Recent Promotions at UCB
-
Jean-Christophe Donck, Vice President, Site Director Braine-l'Alleud
was Vice President, Human Resources, Global Projects - 2 months ago
-
was VP Corporate Business Development & Product Licensing - 2 months ago
-
Cécile Ecoffet, Director, Head of Market Insights
was Global Senior Manager, Patient and Market Insight - 2 months ago
-
Lode Dewulf, VP, Head Global Medical Affairs
was VP Medical Affairs, CNS - 5 months ago
-
Elena Fraser, Regional Business Manager - Neurology
was Head of Epilepsy Marketing International Operations - last month
Last edited by Apllication Analyst at UCB inc.
Allee de la Recherche 60
Brussels
1070
Belgium
Phone: 32 2 559 99 99
| Headquarters | Brussels Area, Belgium |
|---|
| Industry | Pharmaceuticals |
|---|
| Type | Public Company |
|---|
| Status | Operating |
|---|
| Company Size |
10,300 employees
|
|---|
| 2006 Revenue |
2,523
mil
[EUR]
(8%)
|
|---|
| Founded | 1928 |
|---|
| Website | http://www.ucb.com |
|---|
| Top Schools |
| Université catholique de Louvain | 5% |
|
Estimated based on LinkedIn Data
Career path for UCB employees
UCB employees are most connected to
